We demonstrated a higher ERp46/AdipoR1 expression ratio in metastatic compared to non-metastatic ccRCC, as determined by immunohistochemistry of tissue microarrays and subsequent image analysis. This evidence concerns the gene ADIPOR1 and nonpapillary renal cell carcinoma.